Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters
We report a case of a young patient suffering from very-high risk B-acute lymphoblastic leukemia (ALL) refractory to first-line therapy with early central nervous system relapse, sequentially treated with inotuzumab. At this timepoint, the patient showed persistent transfusion-refractory thrombocyto...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Hemato |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-6357/2/2/20 |